» Articles » PMID: 33609076

AS602801 Sensitizes Glioma Cells to Temozolomide and Vincristine by Blocking Gap Junction Communication Between Glioma Cells and Astrocytes

Overview
Journal J Cell Mol Med
Date 2021 Feb 20
PMID 33609076
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies showed that the chemotherapeutic effect of temozolomide (TMZ) and vincristine (VCR) against glioma might be blunted by the co-culture with astrocytes, and connexin-43 (CX43) was thought to play a vital role in the communication between glioma cells and astrocytes. In this study, we aimed to investigate the combined chemotherapeutic effect of AS602801 and TMZ/ VCR in glioma cells both. Dye transfer assay was used to evaluate the gap junction activity between U251 cells and astrocytes. Western blot and immunohistochemistry were carried out to analyse the expression of p-JNK, CX43 and CASP-3 proteins treated under different conditions. AS602801 significantly suppressed the gap junction activity between U251 cells and astrocytes. The expression of p-JNK and CX43 was remarkably inhibited by AS602801. TMZ/VCR-induced apoptosis of glioma cells was effectively enhanced by AS602801 treatment. Accordingly, the inhibitory role of TMZ/VCR in the expression of p-JNK, CX43 and CASP-3 in glioma cells was notably restored by AS602801. Furthermore, in a glioma cell xenograft, AS602801 showed an apparent capability to enhance TMZ/VCR-induced tumour cell apoptosis through altering the expression of p-JNK, CX43 and CASP-3. The findings of this study demonstrated that the co-culture of glioma cells with astrocytes blunted the tumour killing effect of TMZ and VCR. AS602801 down-regulated CX43 expression by inhibiting JNK. And AS602801 also sensitized glioma cells to TMZ/VCR by blocking the gap junction communication between glioma cells and astrocytes via down-regulating CX43, indicating its potential role as a novel adjuvant chemotherapeutic agent in the treatment of glioma.

Citing Articles

Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication.

Wilczynski B, Dabrowska A, Kulbacka J, Baczynska D Cell Commun Signal. 2024; 22(1):486.

PMID: 39390572 PMC: 11468187. DOI: 10.1186/s12964-024-01857-7.


Pharmacological Akt and JNK Kinase Inhibitors 10-DEBC and SP600125 Potentiate Anti-Glioblastoma Effect of Menadione and Ascorbic Acid Combination in Human U251 Glioblastoma Cells.

Despotovic A, Janjetovic K, Zogovic N, Tovilovic-Kovacevic G Biomedicines. 2023; 11(10).

PMID: 37893026 PMC: 10604608. DOI: 10.3390/biomedicines11102652.


Role of protein phosphorylation in cell signaling, disease, and the intervention therapy.

Pang K, Wang W, Qin J, Shi Z, Hao L, Ma Y MedComm (2020). 2022; 3(4):e175.

PMID: 36349142 PMC: 9632491. DOI: 10.1002/mco2.175.


AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.

Zhang S, Gong Y, Wang H, Li Z, Huang Y, Fu X J Cell Mol Med. 2021; 25(8):4062-4072.

PMID: 33609076 PMC: 8051707. DOI: 10.1111/jcmm.16375.

References
1.
Gangoso E, Thirant C, Chneiweiss H, Medina J, Tabernero A . A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype. Cell Death Dis. 2014; 5:e1023. PMC: 4040690. DOI: 10.1038/cddis.2013.560. View

2.
Jacobs V, Valdes P, Hickey W, De Leo J . Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro. 2011; 3(3):e00063. PMC: 3153964. DOI: 10.1042/AN20110014. View

3.
Scemes E, Suadicani S, Spray D . Intercellular communication in spinal cord astrocytes: fine tuning between gap junctions and P2 nucleotide receptors in calcium wave propagation. J Neurosci. 2000; 20(4):1435-45. PMC: 1513543. View

4.
Bullock T, Bennett M, Johnston D, Josephson R, Marder E, Fields R . Neuroscience. The neuron doctrine, redux. Science. 2005; 310(5749):791-3. DOI: 10.1126/science.1114394. View

5.
Yu S, Xiao H, Jiang X, Wang Q, Li Y, Yang X . Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells. 2011; 30(2):108-20. DOI: 10.1002/stem.1685. View